< Terug naar vorige pagina
Onderzoeker
Yves Briers
- Disciplines:Engineering van biomaterialen, Biologische systeemtechnologie, Biomateriaal engineering, Biomechanische ingenieurswetenschappen, Andere (bio)medische ingenieurswetenschappen, Milieu ingenieurswetenschappen en biotechnologie, Industriële biotechnologie, Andere biotechnologie, bio-en biosysteem ingenieurswetenschappen
Affiliaties
- Departement Biosystemen (Departement)
Lid
Vanaf1 aug 2005 → 30 apr 2015
Projecten
1 - 3 of 3
- Ontwikkeling van de nieuwste generatie Artilysines, enzyme-gebaseerde antibiotica tegen multidrug-resistente bacteriënVanaf1 jan 2015 → 30 apr 2015Financiering: FWO Krediet aan Navorser
- Ontwikkeling van de tweede generatie vancomycine-gebaseerde antibioticaVanaf1 apr 2014 → 31 aug 2015Financiering: IOF - Industrieel Onderzoeksfonds
- Studie en exploitatie van bacteriofaaggecodeerde endolysines en exopolysaccharide depolymerasen.Vanaf1 okt 2008 → 31 dec 2008Financiering: BOF - Andere acties
Publicaties
1 - 10 van 34
- The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage(2017)
Auteurs: Dieter Vandenheuvel, Yves Briers, Rob Lavigne
Pagina's: 1203 - 1216 - Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki(2017)
Auteurs: Yves Briers, Rob Lavigne
- Klebsiella phages representing a novel clade of viruses with an unknown DNA modification and biotechnologically interesting enzymes(2017)
Auteurs: Yves Briers, Rob Lavigne
Pagina's: 673 - 684 - Characterization and genome sequencing of a Citrobacter freundii phage CfP1 harboring a lysin active against multidrug-resistant isolates(2016)
Auteurs: Yves Briers
Pagina's: 10543 - 10553 - 'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci(2016)
Auteurs: Rob Lavigne, Sander Govers, Abram Aertsen, Yves Briers
- DUF3380 domain from a Salmonella phage endolysin shows potent N-acetylmuramidase activity(2016)
Auteurs: Hans Gerstmans, Rob Lavigne, Yves Briers
Pagina's: 4975 - 4981 - Characterization of novel bacteriophages for biocontrol of bacterial blight in leek caused by Pseudomonas syringae pv. porri(2016)
Auteurs: Sofie Rombouts, HB Jang, Yves Briers, Rob Lavigne
- Efficacy of Artilysin® Art-175 against resistant and persistent Acinetobacter baumannii(2016)
Auteurs: Valerie Defraine, Sander Govers, Abram Aertsen, Maarten Fauvart, Jan Michiels, Rob Lavigne, Yves Briers
Pagina's: 3480 - 3488 - From endolysins to Artilysins: novel enzyme-based approaches to kill drug-resistant bacteria(2016)
Auteurs: Hans Gerstmans, Rob Lavigne, Yves Briers
Pagina's: 123 - 128 - A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections(2016)
Auteurs: Kasia Danis - Wlodarczyk, Dieter Vandenheuvel, HB Jang, Yves Briers, Rob Lavigne
Patenten
1 - 10 van 10
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- New endolysin obpgplys (Inventor)
- Polynucleotide shuffling method (Inventor)
- Antimicrobial agents (Inventor)
- Polynucleotide shuffling method (Inventor)
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- Antimicrobial agents (Inventor)
- VANCOMYCIN ANALOGS (Inventor)